Healthcare

SB 535 revises laws related to experimental treatments, primarily by requiring experimental treatment centers to obtain a license from the state department. These centers must adhere to operational standards and pay licensing fees. The bill also mandates that licensed centers allocate 2% of their net annual profits to support access to experimental treatments for qualifying Montana residents. This allocation can be fulfilled by providing free treatment or contributing to a new Insurance Premium Support Account. This account is established to help fund health insurance premiums for eligible Montana residents who purchase insurance on the federal marketplace and meet specific income criteria.

HB 740 revises laws affecting pharmacies, pharmacy benefit managers (PBMs), and other entities involved in prescription drug dispensing and reimbursement. The bill establishes new restrictions on how PBMs can audit pharmacies and recoup funds, such as prohibiting recoupment for clerical errors without actual financial harm and banning the use of extrapolation in calculations. It also updates regulations for Maximum Allowable Cost (MAC) lists and reference pricing, requiring PBMs to ensure drugs on MAC lists are available and to frequently update and disclose pricing information to pharmacies.

HJ 35 is a joint resolution from the Montana Legislature urging federal officials to modify current federal land management and wildfire policies. It calls for an aggressive initial attack on wildfires across all federal lands and for federal forest roads to remain open for access and fire suppression. The resolution also recommends that EPA air quality standards include wildfire smoke and that federal "let it burn" policies be reversed, ensuring NEPA processes are followed. Finally, it advocates for increased involvement of state and local governments and stakeholder groups in federal fire management decisions to protect Montana's communities.

HB 476 establishes a grant program to fund the installation and maintenance of newborn safety devices. The Department of Public Health and Human Services will award competitive grants, up to $20,000 per applicant, to eligible fire departments, hospitals, and law enforcement agencies. The department is also responsible for creating rules for the application process and evaluation criteria. The bill appropriates $160,000 from the general fund for this program, which is effective July 1, 2025, and terminates on June 30, 2027.

HB 41 adds gabapentin to Montana's Schedule V list of controlled substances under the "depressants" category. This change directly affects medical providers who prescribe gabapentin (used for nerve pain, seizures, and other conditions), pharmacists who dispense it, and patients using the medication. The bill amends Montana Code § 50-32-232 to explicitly include gabapentin - identified by its chemical name "1-(aminomethyl)cyclohexaneacetic acid" - in Schedule V depressants alongside drugs like pregabalin. This policy update standardizes gabapentin's regulatory classification without altering its medical use or prescribing rules.